Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo-controlled trial

• Published in: The International journal of eating disorders Vol. 45; no. 2; pp. 281 - 289
• Main Authors: Guerdjikova, Anna I., McElroy, Susan L., Winstanley, Erin L., Nelson, Eric B., Mori, Nicole, McCoy, Jessica, Keck Jr, Paul E., Hudson, James I.
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.03.2012; Wiley Subscription Services, Inc
• Subjects: Adolescent; Adult; Aged; Antidepressive Agents - therapeutic use; Binge eating; binge eating disorder; Binge-Eating Disorder - complications; Binge-Eating Disorder - drug therapy; Bulimia; Clinical outcomes; depression; Depressive Disorder - complications; Depressive Disorder - drug therapy; Double-Blind Method; Drug therapy; duloxetine; Duloxetine Hydrochloride; Eating disorders; Female; Humans; Inhibitor drugs; longitudinal analysis; Male; Mental depression; Middle Aged; obesity; Thiophenes - therapeutic use; Treatment Outcome

Objective: This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders. Method: In this 12‐week, double‐blind, placebo‐controlled trial, 40 patients with Diagnostic and Statistical Manual of Mental Disorders‐IV‐TR BED and a comorbid curr...